AC
UTHR icon

Amici Capital’s United Therapeutics UTHR Stock Holding History

Amici Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-81,032
Closed -$11.6M – 40
2016
Q4 		$11.6M Sell
81,032
-14,333
-15% -$1.83M 4.52% 4
2016
Q3 		$11.3M Sell
95,365
-31,086
-25% -$3.74M 2.94% 8
2016
Q2 		$13.4M Sell
126,451
-102,000
-45% -$11.4M 2.52% 10
2016
Q1 		$25.5M Sell
228,451
-256,995
-53% -$32.5M 3.02% 8
2015
Q4 		$76M Sell
485,446
-267,473
-36% -$38.9M 5.33% 2
2015
Q3 		$98.8M Sell
752,919
-81,270
-10% -$13M 4.73% 2
2015
Q2 		$145M Sell
834,189
-121,620
-13% -$21.9M 5.28% 2
2015
Q1 		$165M Sell
955,809
-130,630
-12% -$19.9M 5.92% 2
2014
Q4 		$141M Sell
1,086,439
-12,960
-1% -$1.67M 6.33% 1
2014
Q3 		$141M Buy
1,099,399
+944,200
+608% +$97.3M 4.7% 2
2014
Q2 		$13.7M Sell
155,199
-187,200
-55% -$18M 0.43% 59
2014
Q1 		$32.2M Buy
+342,399
New +$35M 1.06% 36
2013
Q4 		– Sell
-307,130
Closed -$24.2M – 157
2013
Q3 		$24.2M Hold
307,130
– – 0.88% 36
2013
Q2 		$20.2M Buy
+307,130
New +$19.8M 0.74% 37

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amici Capital's UTHR Position: Q1 2017 in Review

Amici Capital sold out of United Therapeutics (UTHR) in Q1 2017, closing a stake of 81,032 shares — an estimated $11.6M sold.

Amici Capital first reported a position in UTHR in Q2 2013 and held it in 14 quarters. The position peaked at $165M in Q1 2015. 411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

  • Amici Capital reported no remaining United Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Amici Capital sold 81,032 United Therapeutics shares in Q1 2017, an estimated $11.6M.
  • Amici Capital first reported a position in United Therapeutics in Q2 2013 and held it in 14 quarters.
  • Amici Capital's United Therapeutics position peaked at $165M in Q1 2015.
  • 411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on Amici Capital's 13F filing for Q1 2017.